The abundance of Firmicutes in the male Nrf2 KO AOM/DSS-treated group (13%) was lower than that in the male WT AOM/DSS-treated (29%) group (Figure 4B, C and Supplementary Figures S4B, C). The gene discussed is NFE2L2; the disease is infectious otitis media.